##{"id":84782,"date":"2020-02-07T14:39:29","date_gmt":"2020-02-07T03:39:29","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=84782"},"modified":"2020-02-07T14:39:29","modified_gmt":"2020-02-07T03:39:29","slug":"sponsored-creso-pharmas-cannabis-technological-breakthrough","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2020\/02\/07\/sponsored-creso-pharmas-cannabis-technological-breakthrough\/","title":{"rendered":"SPONSORED: Creso Pharma\u2019s Cannabis Technological Breakthrough"},"content":{"rendered":"<p style=\"text-align:center\"><em>&#8211;The below is a company sponsored announcement&#8211;<\/em><\/p>\n<hr \/>\n<p style=\"text-align:justify\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.fnarena.com\/ckfinder\/userfiles\/images\/CPH%20hero%20image.jpg\" style=\"height:432px;width:768px\" \/><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong><span style=\"font-family:calibri,sans-serif\">Creso Pharma Limited ((CPH)), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as it aims to brings the best of cannabis to better the lives of people and animals. <\/span><\/strong><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">Creso develops cannabis and hemp-derived therapeutic, nutraceutical, and life style products with wide patient and consumer reach for human and animal health. It has worldwide rights for a number of unique and proprietary innovative delivery technologies<\/span> <span style=\"font-family:calibri,sans-serif\">which enhance the bioavailability and absorption of cannabinoids.<\/span>&nbsp;<\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">This week, the company achieved a key technological milestone, developing its first water-soluble microgranulated hemp plant granules product as an expansion of its cannaQIX&reg; human health product line.<\/span><\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">The news comes directly after the company announced it had sold over 2.5 million cannaQIX&reg; lozenges (the equivalent of 100,000 pack sold) since the human health product&rsquo;s launch in April 2018. <\/span><\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">Today&rsquo;s announcement marks a further milestone in the growth of Creso&rsquo;s human health product line.<\/span><\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">The new technology has been developed over the past nine months in conjunction with Switzerland&rsquo;s Domaco Pharma and allows hemp oil-free manufacturing of cannaQIX&reg; hemp plant-based gum arabicum lozenges, Creso Pharma&rsquo;s hemp and vitamin-based food supplement.<\/span><\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">This development is significant for several reasons. <\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">Firstly, <\/span><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">the technological breakthrough will be used to extend Creso&rsquo;s successful cannaQIX&reg; product line.<\/span><\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">Secondly, the new technology allows hemp oil free production, bringing the full benefit of the natural hemp plant to the consumers. <\/span><\/span><\/p>\n<p><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">Furthermore, the product offers significant regulatory advantages in several countries. Importantly, the &nbsp;formulation contains hemp compounds which are already approved for use in consumer products, providing Creso with a path to market for food supplement products without the need for regulatory approval.<\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">&ldquo;With the achievement of this innovation of the oil free hemp based technology Creso successfully addresses the regulatory and market access challenges enabling us to enter additional markets on a global basis,&rdquo; said <\/span><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">Dr. Gian Trepp<\/span><\/span><span style=\"font-family:calibri,sans-serif\">, Creso&rsquo;s R&amp;D\/Commercial Director.<\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">As with most Creso products, this new product helps to manage stress and improves well-being in its consumers and comes at a time when there is a growing desire globally for alternative natural stress and pain management products.<\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">The product opens up a range of new territories for Creso.<\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">&ldquo;The new products contain various hemp compounds which are already approved for use in consumer products,&rdquo; said <\/span><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">Dr. Miri Halperin Wernli, Co-Founder and CEO of Creso Pharma.<\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:calibri,sans-serif\">&ldquo;Importantly, this means that we have an additional path to market for our hemp-based food supplements without the need for regulatory approval, thus<\/span><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\"> increasing our commercial options and expanding the potential territories we can sell the products in.&rdquo;<\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"color:black\"><span style=\"font-family:calibri,sans-serif\">Creso plans to distribute the new products globally with different commercial partners in several countries and expects that the products will be ready for launch in Q3 2020.<\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><em><span style=\"font-family:calibri,sans-serif\">By Jonathan Jackson<\/span><\/em><\/span><\/p>\n<hr \/>\n<p><em>Earlier today the corporate announcement above was publicly released. FNArena is acting as a partner in&nbsp;distribution to broaden the reach. No journalists have been involved in the re-publication of this announcement.<\/em><\/p>\n<p><em>Find out why FNArena subscribers like the service so much: &quot;<a href=\"http:\/\/www.fnarena.com\/index4.cfm?type=dsp_newsitem&amp;n=29EB960D-9DFF-C00E-7F6B464E5D52E250\">Your Feedback (Thank You)<\/a>&quot; &#8211; Warning this story contains unashamedly positive feedback on the service provided.<\/em><\/p>\n<p><em>FNArena&nbsp;is proud about its track record and past achievements: <a href=\"https:\/\/www.fnarena.com\/index.php\/2018\/10\/03\/rudis-view-ten-years-on-the-world-is-still-turning\/\">Ten Years On<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creso Pharma, ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as it aims to bring the best of cannabis to better the lives of people and animals.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/84782"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=84782"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/84782\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=84782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=84782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=84782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}